Antonio Gasbarrini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Antonio Gasbarrini has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Adelaide Panariello
Department of Mental Health and Addiction Services, Niguarda Hospital, Milan, Italy
1 shared publication- Alessandra Feltrin
Hospital Psychology, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy
1 shared publication Andrea Ronzan
Psychiatry Unit, Padua University Hospital, Padua, Italy
1 shared publication- Antonio Grieco
Department of Medical and Surgical Sciences, CEMAD, Fondazione Policlinico Universitario Agostino Gemelli IRCCS , Rome, Italy
1 shared publication - Barbara Lattanzi
Department of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy
1 shared publication - Chiara Mazzarelli
Hepatology and Gastroenterology Unit, ASST Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore 3, 20162 Milan, Italy
1 shared publication
Latest Publications
- Open Access
- 25 December 2021
- Published by Elsevier in American Journal of Transplantation
- Vol. 22 (4) , 1191-1200
Liver transplantation for severe alcoholic hepatitis: A multicenter Italian study
- 25 December 2021
- Published by Elsevier in American Journal of Transplantation
- Vol. 22 (4) , 1191-1200
Open AccessLiver transplantation for severe alcoholic hepatitis: A multicenter Italian study
- 14 January 2020
- Published by Springer Nature in Intensive Care Medicine
- Vol. 46 (2) , 215-224
Clostridioides difficile (formerly Clostridium difficile) infection in the critically ill: an expert statement
Clostridioides difficile (formerly Clostridium difficile) infection (CDI) represents a worrisome condition, often underestimated, with severe clinical presentations, frequently requiring intensive care unit (ICU) admission. The aim of the present expert statement was to give an overview of the management of CDI in critically ill patients, for whom CDI represents a redoubtable problem, in large part related to the use and abuse of antibiotics. The available knowledge about pathophysiology, risk factors, diagnosis and treatment concerning critical care patients affected by CDI has been reviewed, even though most of the existing information come from studies performed outside the ICU and the evidence on several issues in this specific context is scarce. The adoption of potential preventive and therapeutic strategies aimed to stem the phenomenon were discussed, including the faecal microbiota transplantation. This possibility could represent a highly interesting option in critically ill patients, but current evidence is limited and future well designed studies are needed. A special insight on the specific challenges that the ICU physicians may face caring for the critically ill patients with CDI was also proposed.
- 14 January 2020
- Published by Springer Nature in Intensive Care Medicine
- Vol. 46 (2) , 215-224
Clostridioides difficile (formerly Clostridium difficile) infection in the critically ill: an expert statement
Clostridioides difficile (formerly Clostridium difficile) infection (CDI) represents a worrisome condition, often underestimated, with severe clinical presentations, frequently requiring intensive care unit (ICU) admission. The aim of the present expert statement was to give an overview of the management of CDI in critically ill patients, for whom CDI represents a redoubtable problem, in large part related to the use and abuse of antibiotics. The available knowledge about pathophysiology, risk factors, diagnosis and treatment concerning critical care patients affected by CDI has been reviewed, even though most of the existing information come from studies performed outside the ICU and the evidence on several issues in this specific context is scarce. The adoption of potential preventive and therapeutic strategies aimed to stem the phenomenon were discussed, including the faecal microbiota transplantation. This possibility could represent a highly interesting option in critically ill patients, but current evidence is limited and future well designed studies are needed. A special insight on the specific challenges that the ICU physicians may face caring for the critically ill patients with CDI was also proposed.